Flavonoids inhibit estrogen binding to rat alpha-fetoprotein

Area of Science:

• Biochemistry
• Endocrinology
• Pharmacology

Background:

• Plant-derived bioflavonoids are of interest for their potential roles in regulating steroid hormone action.
• Studies on bioflavonoids often involve neonatal rats with high levels of alpha-fetoprotein (AFP), which binds estradiol.
• Interactions between bioflavonoids and AFP may alter estrogen availability and bioflavonoid actions.

Purpose of the Study:

• To investigate the effect of various flavonoids and isoflavonoids on estrogen binding to rat AFP.
• To determine the structural requirements for bioflavonoid binding to AFP.
• To assess the potential in vivo implications of these interactions for endocrine regulation and experimental studies.

Main Methods:

• Tested the binding affinities (Kd) of several flavonoids (quercetin, rutin, naringenin, etc.) and isoflavonoids (daidzein, genistein) to rat AFP.
• Analyzed the influence of hydroxyl and glucoside substituents on flavonoid structure for AFP binding.
• Considered molecular modeling to elucidate binding mechanisms.

Main Results:

• Naringenin, quercetin, and kaempferol inhibited estrogen binding to AFP with Kds around 5 x 10(-7) M.
• Daidzein and genistein showed lower affinity (Kds around 5 x 10(-6) M), indicating AFP specificity for flavonoid structures.
• 5,7-hydroxyl groups on ring A and a 4'-hydroxyl group on ring B were identified as important for AFP binding.

Conclusions:

• Flavonoids and isoflavonoids can modulate estradiol and estrone binding to rat AFP in vivo at dietary levels.
• The binding affinity of bioflavonoids to AFP suggests they can alter the potency of plant estrogens.
• Dietary flavonoid levels are crucial considerations in endocrine studies, especially during development, and bioflavonoids can serve as tools to understand estrogen actions.